Rosiglitazone treatment improves insulin regulation and dyslipidemia in type 2 diabetic cynomolgus monkeys.
Gee MK, Zhang L, Rankin SE, Collins JN, Kauffman RF, Wagner JD. Rosiglitazone treatment improves insulin regulation and dyslipidemia in type 2 diabetic cynomolgus monkeys. Metabolism. 2004 Sep; 53(9):1121-5.